Why do regulatory firms sometimes underperform?
Peer-Reviewed Publication
Updates every hour. Last Updated: 14-Jul-2025 06:11 ET (14-Jul-2025 10:11 GMT/UTC)
In a new study, “Mitigating Ingroup Bias in Regulatory Firms: The Role of Inspector Professionalism,” researchers considered ingroup bias to examine why regulatory firms sometimes underperform in their duties; they also looked at the effect of inspectors’ professionalism. The study uncovered evidence of ingroup bias and found that inspectors’ professionalism lessens the effect of that bias on the stringency of regulatory enforcement.
A new study finds that CivicaScript, a not-for-profit drug manufacturer in the US, can reliably supply essential generic medicines at a price that saves patients over 60%, and public and private insurers over 90%, demonstrating the potential of the nonprofit health care utility (HCU) model to deliver a scalable solution to generic drug affordability.
Research team from Nanjing University proposed FOCUS, a causal model-based offline RL algorithm, which uses causal structure to improve policy generalization, outperforming baselines in offline settings.
New research in Health Economics reveals the impact that cannabis laws have had on such traditional prescriptions.